sulbactam has been researched along with Intraabdominal Infections in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SP; Chao, CM; Lai, CC; Lan, SH; Lu, LC | 1 |
| Pesotskiĭ, ON | 1 |
| Chen, CW; Ma, CJ; Ming, CC; Shan, YS; Wang, JY; Yeh, YS | 1 |
| Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Boĭko, VV; Ivanova, IuV | 1 |
1 review(s) available for sulbactam and Intraabdominal Infections
| Article | Year |
|---|---|
Clinical Efficacy and Safety of Cefoperazone-Sulbactam in Treatment of Intra-Abdominal Infections: A Systematic Review and Meta-Analysis.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Humans; Intraabdominal Infections; Sulbactam; Treatment Outcome | 2021 |
1 trial(s) available for sulbactam and Intraabdominal Infections
| Article | Year |
|---|---|
Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Aza Compounds; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Intraabdominal Infections; Logistic Models; Male; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Risk Factors; Sulbactam; Taiwan; Treatment Outcome; Young Adult | 2013 |
3 other study(ies) available for sulbactam and Intraabdominal Infections
| Article | Year |
|---|---|
[Application of gepacef comby for an acute surgical diseases of organs of the hepatopancreatobiliary zone].
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Cefoperazone; Cholecystitis; Drug Combinations; Female; Humans; Intraabdominal Infections; Liver Abscess; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Sulbactam; Treatment Outcome; Young Adult | 2013 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
[Comparative estimation of the application efficacy for ceftriaxon and Hepacef combi preparations in the abdominal infection treatment].
Topics: Abdominal Cavity; Adult; Anti-Bacterial Agents; Blood Cell Count; Cefoperazone; Ceftriaxone; Drug Administration Schedule; Drug Combinations; Drug Synergism; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intraabdominal Infections; Male; Middle Aged; Postoperative Complications; Sulbactam; Treatment Outcome; Ukraine | 2012 |